These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 27445167

  • 1. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
    Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH.
    Clin J Am Soc Nephrol; 2016 Oct 07; 11(10):1752-1759. PubMed ID: 27445167
    [Abstract] [Full Text] [Related]

  • 2. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
    Swarnalatha G, Ram R, Ismal KM, Vali S, Sahay M, Dakshinamurty KV.
    Saudi J Kidney Dis Transpl; 2015 Jan 07; 26(1):173-81. PubMed ID: 25579744
    [Abstract] [Full Text] [Related]

  • 3. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.
    Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH.
    Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):386-94. PubMed ID: 26912551
    [Abstract] [Full Text] [Related]

  • 4. Association of histologic variants in FSGS clinical trial with presenting features and outcomes.
    D'Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC.
    Clin J Am Soc Nephrol; 2013 Mar 07; 8(3):399-406. PubMed ID: 23220425
    [Abstract] [Full Text] [Related]

  • 5. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS.
    Am J Kidney Dis; 2021 Feb 07; 77(2):216-225. PubMed ID: 32791086
    [Abstract] [Full Text] [Related]

  • 6. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS.
    Clin J Am Soc Nephrol; 2018 Mar 07; 13(3):414-421. PubMed ID: 29167190
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R, Nada R, Yadav AK, Kumar A, Goyal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.
    Ren Fail; 2016 Jul 07; 38(6):894-8. PubMed ID: 27266801
    [Abstract] [Full Text] [Related]

  • 8. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM.
    Rev Assoc Med Bras (1992); 2024 Jul 07; 70(4):e20230871. PubMed ID: 38716932
    [Abstract] [Full Text] [Related]

  • 9. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
    He HG, Wu CQ, Ye K, Zeng C, Huang YY, Luo SW, Yin W, Ye QR, Peng XM.
    BMC Nephrol; 2019 Aug 22; 20(1):328. PubMed ID: 31438882
    [Abstract] [Full Text] [Related]

  • 10. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug 22; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 11. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.
    Markowitz GS, Nasr SH, Stokes MB, D'Agati VD.
    Clin J Am Soc Nephrol; 2010 Apr 22; 5(4):607-15. PubMed ID: 20203164
    [Abstract] [Full Text] [Related]

  • 12. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S, Agarwal S, Kalaivani M, Bhowmik D, Singh G, Mahajan S, Dinda A.
    Nephron; 2016 Apr 22; 132(2):81-5. PubMed ID: 26799973
    [Abstract] [Full Text] [Related]

  • 13. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 22; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 14. Differential risk of remission and ESRD in childhood FSGS.
    Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB.
    Pediatr Nephrol; 2006 Mar 22; 21(3):344-9. PubMed ID: 16395603
    [Abstract] [Full Text] [Related]

  • 15. Complete Remission in the Nephrotic Syndrome Study Network.
    Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.
    Clin J Am Soc Nephrol; 2016 Jan 07; 11(1):81-9. PubMed ID: 26656320
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun 07; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 17. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
    Zhang YM, Gu QH, Huang J, Qu Z, Wang X, Meng LQ, Wang F, Liu G, Cui Z, Zhao MH.
    Clin J Am Soc Nephrol; 2016 Sep 07; 11(9):1582-1589. PubMed ID: 27340287
    [Abstract] [Full Text] [Related]

  • 18. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar 07; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 19. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 07; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 20. Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression and proteinuria remission.
    Kawaguchi T, Imasawa T, Kadomura M, Kitamura H, Maruyama S, Ozeki T, Katafuchi R, Oka K, Isaka Y, Yokoyama H, Sugiyama H, Sato H.
    Nephrol Dial Transplant; 2022 Aug 22; 37(9):1679-1690. PubMed ID: 34499164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.